A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone
← catalyst calendarSponsored by Eli Lilly and Company (industry) · LLY — their whole pipeline →.
Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
559actual
Sites
89
Countries
China, India, Japan +3
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2023-08-09 | actual | When the study began enrolling |
| Primary completion | 2025-04-03 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-04-03 | actual | The whole study's end, after follow-up |
| First posted | 2023-08-02 | actual | When this record first appeared on the registry |
| Results posted | 2026-04-22 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-04-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Type 2 Diabetes
Interventions
- Drug: Orforglipron — also filed as LY3502970
- Drug: Placebo
Primary outcome
what the primary-completion date above is the date OFChange From Baseline in HbA1c
measured Baseline, Week 40
Posted documents
hosted by the registry — we link, never re-serveStudy Protocolposted 2023-09-06 · 17.6 MB · Prot_000.pdf
Statistical Analysis Planposted 2025-03-14 · 8.6 MB · SAP_001.pdf
Publications
- PMID 40544435 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · LLY's whole pipeline · Catalyst calendar · Every registered study · What changed